Gut metagenomic and short chain fatty acids signature in hypertension: a cross-sectional study
Data de publicació2020-04-15
Gosalbes, Maria José
Valls, Rosa M.
Ludwig, Iziar A.
MetadadesMostra el registre d'unitat complet
Hypertension is an independent and preventable risk factor for the development of cardiovascular diseases, however, little is known about the impact of gut microbiota composition in its development. We carried out comprehensive gut microbiota analysis and targeted metabolomics in a cross-sectional study of 29 non-treated hypertensive (HT) and 32 normotensive (NT) subjects. We determined fecal microbiota composition by 16S rRNA gene sequencing and bacterial functions by metagenomic analysis. The microbial metabolites analysed were short chain fatty acids (SCFA) both in plasma and feces, and trimethylamine N-oxide (TMAO) in plasma. The overall bacterial composition and diversity of bacterial community in the two groups were not significantly different. However, Ruminococcaceae NK4A214, Ruminococcaceae_UCG-010, Christensenellaceae_R-7, Faecalibacterium prausnitzii and Roseburia hominis were found to be significantly enriched in NT group, whereas, Bacteroides coprocola, Bacteroides plebeius and genera of Lachnospiraceae were increased in HT patients. We found a positive correlation between the HT-associated species and systolic and diastolic blood pressure after adjusted for measured confounders. SCFA showed antagonistic results in plasma and feces, detecting in HT subjects significant higher levels in feces and lower levels in plasma, which could indicate a less efficient SCFA absorption. Overall, our results present a disease classifier based on microbiota and bacterial metabolites to discriminate HT individuals from NT controls in a first disease grade prior to drug treatment.
És part deScientific Reports, 2020, vol. 10, p. 6436
Projectes de recerca europeus
Aquest document està subjecte a una llicència Creative Commons.cc-by (c) Calderón-Pérez, Lorena et al., 2020
Mostrant elements relacionats per títol, autor i matèria.
Effects of hesperidin in orange juice on blood and pulse pressures in mildly hypertensive individuals: a randomized controlled trial (Citrus study) Valls, Rosa M.; Pedret, Anna; Calderón-Pérez, Lorena; Llauradó, Elisabet; Pla-Pagà, Laura; Companys, Judit; Moragas, Ana; Martín Luján, Francisco Manuel; Ortega, Yolanda; Giralt, Montserrat; Romeu, Marta; Rubió Piqué, Laura; Mayneris Perxachs, Jordi; Canela, Núria; Puiggròs i Llavinés, Francesc; Caimari, Antoni; Bas, Josep M. del; Arola i Ferrer, Lluís; Solà, Rosa (Springer, 2020-07-13)Purpose: To assess the sustained and acute effects, as well as the influence of sustained consumption on the acute effects, of orange juice (OJ) with a natural hesperidin content and hesperidin-enriched OJ (EOJ) on blood ...
The effects and associations of whole-apple intake on diverse cardiovascular risk factors. A narrative review Sandoval-Ramírez, Berner Andrée; Catalán Santos, Úrsula; Calderón-Pérez, Lorena; Companys, Judit; Pla-Pagà, Laura; Ludwig, Iziar A.; Romero Fabregat, Mª Paz; Solà, Rosa (Taylor & Francis Group, 2020-01-13)Apples are among the world’s most consumed fruits. However, while the impact of whole-apple intake on cardiovascular disease (CVD) remains unknown. This narrative review summarizes a novel integrated view of whole-apple ...
Granado-Serrano, Ana Belén; Martín Garí, Meritxell; Sánchez, V.; Riart Solans, M.; Berdún Hernández, Rebeca; Ludwig, Iziar A.; Rubió Piqué, Laura; Vilaprinyo Terré, Ester; Portero Otín, Manuel; Serrano Casasola, José Carlos Enrique (Nature Research, 2019)Gut microbiota has been suggested to affect lipid metabolism. The objective of this study was to characterize the faecal microbiota signature and both short chain fatty acids (SCFAs) and bile acids (BA) profile of ...